Neuland Laboratories logo

Neuland Laboratories CEO, MD, chairman, board of directors and AGM

NSE: NEULANDLABBSE: 524558Pharmaceuticals & BiotechnologySmall Cap

Last close ₹18,865.00down ₹70.00 (0.37%)BSE ₹18,924.25

Share price at the NSE close on 23 Oct 2026. Previous close ₹18,935.00.

52-week range of traded prices to 23 Oct 2026
₹11,500.00Low, 23 Mar 2026₹24,225.00High, 9 Sep 2026
Market cap
₹24,204 Cr356th largest listed
P/E
48.6
P/B
12.9
Dividend yield
0.18%
ROE
29.3%
ROCE
32.1%
Debt to equity
0.10
Volume, NSE
53,34748.3% delivered

Neuland Laboratories board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonDavuluri Rama Mohan RaoRelated to the promoter
  • Managing director and CEODavuluri Saharsh Rao
  • Company Secretary and Compliance OfficerSarada Bhamidipati

9 directors5 independent3 executive1 non-executive

  • Davuluri Rama Mohan Rao · ChairpersonExecutive · joined Jul 1984 · reappointed Jul 1984 · 1 listed board
  • Davuluri Sucheth RaoExecutive · joined Jul 2003 · reappointed Jul 2003 · 1 listed board · 1 committee seat
  • Davuluri Saharsh Rao · Managing director and CEOExecutive · joined May 2009 · reappointed May 2009 · 1 listed board · 1 committee seat
  • Homi Rustam KhusrokhanIndependent · joined Feb 2019 · reappointed Feb 2024 · 89 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 2 as chair
  • Prasad Raghava MenonIndependent · joined Oct 2022 · reappointed Oct 2022 · 44 months as independent · 3 listed boards · 3 as independent · 3 committee seats
  • Sugata SircarIndependent · joined Jun 2023 · reappointed Jun 2023 · 36 months as independent · 1 listed board · 1 as independent · 1 committee seat
  • Pallavi Joshi BhakruIndependent · joined Jun 2023 · reappointed Jun 2023 · 36 months as independent · 2 listed boards · 2 as independent · 3 committee seats, 2 as chair
  • Ravi Shankar GopinathIndependent · joined Aug 2025 · reappointed Aug 2025 · 11 months as independent · 2 listed boards · 2 as independent
  • Mauricio FutranNon-executive · joined May 2026 · reappointed May 2026 · 1 listed board

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

2 directors who left
  • Christopher M Cimarusti, left 28 Feb 2026: Others
  • Nirmala Murthy, left 7 May 2025: Tenure Completion

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 12 May 20269 of 9 present5 independent · 90 days in between
    • 10 Feb 20268 of 9 present5 independent
    • 9 Feb 20268 of 9 present5 independent

  • Audit Committee

    Chair Homi Rustam Khusrokhan

    Sugata Sircar, Pallavi Joshi Bhakru, Prasad Raghava Menon

    • 12 May 20264 of 4 present4 independent · 91 days in between
    • 9 Feb 20264 of 4 present4 independent

  • Nomination and remuneration committee

    Chair Homi Rustam Khusrokhan

    Prasad Raghava Menon, Pallavi Joshi Bhakru

    • 30 Apr 20263 of 3 present3 independent

  • Stakeholders Relationship Committee

    Chair Pallavi Joshi Bhakru

    Davuluri Sucheth Rao, Davuluri Saharsh Rao

    • 8 May 20263 of 3 present1 independent · 87 days in between
    • 9 Feb 20263 of 3 present1 independent

  • Risk Management Committee

    Chair Prasad Raghava Menon

    Homi Rustam Khusrokhan, Davuluri Sucheth Rao, Davuluri Saharsh Rao, Ravi Shankar Gopinath

    • 11 May 20265 of 5 present3 independent · 97 days in between
    • 2 Feb 20264 of 4 present2 independent

  • Corporate Social Responsibility Committee

    Chair Prasad Raghava Menon

    Davuluri Rama Mohan Rao, Davuluri Sucheth Rao, Davuluri Saharsh Rao, Pallavi Joshi Bhakru

    • 8 May 20265 of 5 present2 independent · 87 days in between
    • 9 Feb 20265 of 5 present2 independent

  • Strategy and Technology Committee

    Chair Ravi Shankar Gopinath

    Davuluri Rama Mohan Rao, Davuluri Sucheth Rao, Davuluri Saharsh Rao, Mauricio Futran

    No meeting listed in the filing.

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Jun 2026.

  • M S K A & Associates LLP, Chartered AccountantsPeer-review certificate valid to Jul 2027
1 earlier auditor
  • M/s M S K A & AssociatesNamed in filings from Mar 2025 to Jun 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Neuland Laboratories AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Neuland Laboratories dividend history

Annual general meeting, 4 Aug 2026

45,471 shareholders on the register on 28 Jul 2026; present: 9 promoters and 72 others; votes counted by CS Shaik Razia / D.Hanumanta Raju & Co..The company's voting result (opens in a new tab)

  1. To receive, consider and adopt: (a) the Audited Financial Statements of the Company for the financial year ended March 31, 2026, together with the reports of the Board of Directors and the Auditors’ thereon; and (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the report of the Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 64.34% · promoters 99.34% · institutions 84.50% · other public 3.08%

  2. To declare final dividend of Rs. 34.00/- (340 %) per equity share of a face value of Rs. 10 each, for the financial year 2025-26 as recommended by the Board
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 64.35% · promoters 99.34% · institutions 84.51% · other public 3.09%

  3. To appoint a Director in place of Dr. Davuluri Rama Mohan Rao (DIN: 00107737), who retires by rotation and being eligible, offers himself for re-appointment
    OrdinaryPromoters have an interest in it
    99.76% for0.24% against

    Against: promoters 0.00% · institutions 0.50% · other public 0.00%

    Turnout: all 64.34% · promoters 99.34% · institutions 84.51% · other public 3.08%

  4. Payment of Commission to the Non-executive Directors of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 64.34% · promoters 99.34% · institutions 84.51% · other public 3.08%

  5. Appointment of Dr. Mauricio Futran (DIN: 11699767) as Non-Executive Non-Independent Director of the Company
    Ordinary
    99.63% for0.37% against

    Against: promoters 0.00% · institutions 0.76% · other public 0.00%

    Turnout: all 64.34% · promoters 99.34% · institutions 84.51% · other public 3.08%

  6. Payment of professional fees to Dr. Mauricio Futran (DIN: 11699767) Non-Executive Non-Independent Director of the Company
    Ordinary
    99.54% for0.46% against

    Against: promoters 0.00% · institutions 0.94% · other public 0.00%

    Turnout: all 64.34% · promoters 99.34% · institutions 84.51% · other public 3.08%

  7. Ratification of remuneration of Cost Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 64.37% · promoters 99.34% · institutions 84.51% · other public 3.15%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 5 Nov 2025, 2 resolutions

45,533 shareholders on the register on 3 Oct 2025; votes counted by Shaik Razia / D. Hanumanta Raju & Co..The company's voting result (opens in a new tab)

  1. Re-designation of Mr. Davuluri Sucheth Rao (DIN: 00108880) as Executive Vice Chairman
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 56.43% · promoters 98.79% · institutions 70.94% · other public 2.72%

  2. Re-designation of Mr. Davuluri Saharsh Rao (DIN: 02753145) as Chief Executive Officer and Managing Director
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 56.43% · promoters 98.79% · institutions 70.94% · other public 2.72%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 26 Sep 2025, 1 resolution

45,705 shareholders on the register on 22 Aug 2025; votes counted by Mohit Kumar Goyal / D. Hanumanta Raju & Co..The company's voting result (opens in a new tab)

  1. To approve the appointment of Dr. Ravi Shankar Gopinath (DIN: 00803847), as an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.17%

    Turnout: all 62.33% · promoters 98.58% · institutions 89.62% · other public 3.20%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Jul 2025, 7 resolutions

46,122 shareholders on the register on 23 Jul 2025; present: 9 promoters and 67 others; votes counted by CS D.Hanumanta Raju / D.Hanumanta Raju & Co..The company's voting result (opens in a new tab)

  1. To receive, consider and adopt: (a) the Audited Financial Statements of the Company for the financial year ended March 31, 2025, together with the reports of the Board of Directors and the Auditors’ thereon; and (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, together with the report of the Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 63.67% · promoters 100.00% · institutions 70.55% · other public 23.83%

  2. To declare final dividend of Rs. 12.00/- (120 %) per equity share of a face value of Rs. 10 each, for the financial year 2024-25 as recommended by the Board.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 63.74% · promoters 100.00% · institutions 70.74% · other public 23.83%

  3. To appoint a Director in place of Dr. Christopher M. Cimarusti (DIN: 02872948) who retires by rotation and, being eligible, offers himself for re-appointment.
    Special
    99.30% for0.70% against

    Against: promoters 0.00% · institutions 1.96% · other public 0.00%

    Turnout: all 63.73% · promoters 100.00% · institutions 70.74% · other public 23.83%

  4. To appoint a Director in place of Mr. Davuluri Saharsh Rao (DIN: 02753145) who retires by rotation and, being eligible, offers himself for re-appointment.
    OrdinaryPromoters have an interest in it
    99.46% for0.54% against

    Against: promoters 0.00% · institutions 1.50% · other public 0.00%

    Turnout: all 63.73% · promoters 100.00% · institutions 70.74% · other public 23.83%

  5. Appointment of Secretarial Auditor of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 63.73% · promoters 100.00% · institutions 70.73% · other public 23.83%

  6. Re-appointment of Mr. Davuluri Saharsh Rao (DIN: 02753145), as Whole Time Director, designated as Vice Chairman & Managing Director
    SpecialPromoters have an interest in it
    86.93% for13.07% against

    Against: promoters 0.00% · institutions 36.39% · other public 0.99%

    Turnout: all 63.73% · promoters 100.00% · institutions 70.74% · other public 23.83%

  7. Ratification of remuneration of Cost Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 63.73% · promoters 100.00% · institutions 70.74% · other public 23.83%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 31 Jul 2024, 6 resolutions

Present: 8 promoters and 61 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt: (a) the Audited Financial Statements of the Company for the financial year ended March 31, 2024, together with the reports of the Board of Directors and the Auditors’ thereon; and (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, together with the report of the Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 58.89% · promoters 96.95% · institutions 83.36% · other public 0.59%

  2. To declare final dividend of Rs. 14.00/- [140 %] per equity share of a face value of Rs.10 each, for the financial year 2023-24 as recommended by the Board
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 59.16% · promoters 96.95% · institutions 84.18% · other public 0.59%

  3. To appoint a Director in place of Dr. Davuluri Rama Mohan Rao (DIN: 00107737) who retires by rotation and, being eligible, offers himself for re-appointment
    OrdinaryPromoters have an interest in it
    98.72% for1.28% against

    Against: promoters 0.00% · institutions 2.78% · other public 0.26%

    Turnout: all 59.16% · promoters 96.95% · institutions 84.18% · other public 0.59%

  4. To appoint a Director in place of Mr. Davuluri Sucheth Rao (DIN: 00108880) who retires by rotation and, being eligible, offers himself for re-appointment
    OrdinaryPromoters have an interest in it
    99.76% for0.24% against

    Against: promoters 0.00% · institutions 0.52% · other public 0.69%

    Turnout: all 59.16% · promoters 96.95% · institutions 84.18% · other public 0.59%

  5. To reappoint statutory auditors of the Company and fix their remuneration
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.26%

    Turnout: all 59.16% · promoters 96.95% · institutions 84.18% · other public 0.59%

  6. Ratification of remuneration of Cost Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.26%

    Turnout: all 59.16% · promoters 96.95% · institutions 84.18% · other public 0.59%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 27 Jul 2023, 12 resolutions

Present: 9 promoters and 67 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt: (a) the Audited Financial Statements of the Company for the financial year ended March 31, 2023, together with the reports of the Board of Directors and the Auditors’ thereon; and (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2023, together with the report of the Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 68.04% · promoters 100.00% · institutions 92.79% · other public 18.34%

  2. To declare final dividend of Rs. 10.00/- [100 %] per equity share of a face value of Rs.10 each, for the financial year 2022-23 as recommended by the Board
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 68.30% · promoters 100.00% · institutions 93.76% · other public 18.34%

  3. To appoint a Director in place of Dr.Christopher Cimarusti (DIN: 02872948) who retires by rotation and, being eligible, offers himself for re-appointment
    Special
    99.64% for0.36% against

    Against: promoters 0.00% · institutions 0.96% · other public 0.00%

    Turnout: all 68.30% · promoters 100.00% · institutions 93.76% · other public 18.34%

  4. To adopt a new set of Articles of Association of the Company as per the Companies Act, 2013
    Special
    85.57% for14.43% against

    Against: promoters 0.00% · institutions 66.18% · other public 0.00%

    Turnout: all 54.70% · promoters 100.00% · institutions 43.82% · other public 18.34%

  5. Re-appointment of Mr. Davuluri Sucheth Rao (DIN: 00108880), as Whole Time Director, designated as Vice Chairman & Chief Executive Officer
    SpecialPromoters have an interest in it
    86.07% for13.93% against

    Against: promoters 0.00% · institutions 61.24% · other public 0.00%

    Turnout: all 55.36% · promoters 100.00% · institutions 46.25% · other public 18.34%

  6. Appointment of Mr. Sugata Sircar (DIN: 01119161), as an Independent Director of the Company
    Special
    91.31% for8.69% against

    Against: promoters 0.00% · institutions 23.25% · other public 0.00%

    Turnout: all 68.30% · promoters 100.00% · institutions 93.76% · other public 18.34%

  7. Appointment of Ms. Pallavi Bhakru (DIN: 01526618), as an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 68.30% · promoters 100.00% · institutions 93.76% · other public 18.34%

  8. Continuation of directorship of Mrs. Bharati Rao (DIN: 01892516), as Non-Executive Independent Director on attaining the age of 75 years
    Special
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.33% · other public 0.01%

    Turnout: all 68.30% · promoters 100.00% · institutions 93.76% · other public 18.34%

  9. Re-appointment of Mr. Homi Rustam Khusrokhan (DIN: 00005085), as an Independent Director of the Company for a further period of five years
    Special
    88.83% for11.17% against

    Against: promoters 0.00% · institutions 29.88% · other public 0.00%

    Turnout: all 68.30% · promoters 100.00% · institutions 93.76% · other public 18.34%

  10. Re-appointment of Dr. Davuluri Rama Mohan Rao (DIN: 00107737), as Whole Time Director, designated as Executive Chairman
    SpecialPromoters have an interest in it
    86.07% for13.93% against

    Against: promoters 0.00% · institutions 61.24% · other public 0.00%

    Turnout: all 55.36% · promoters 100.00% · institutions 46.25% · other public 18.34%

  11. Revision in remuneration payable to Mr. Davuluri Saharsh Rao (DIN: 02753145), Whole Time Director, designated as Vice Chairman & Managing Director
    SpecialPromoters have an interest in it
    86.03% for13.97% against

    Against: promoters 0.00% · institutions 61.24% · other public 0.36%

    Turnout: all 55.36% · promoters 100.00% · institutions 46.25% · other public 18.34%

  12. Ratification of remuneration of Cost Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 68.30% · promoters 100.00% · institutions 93.76% · other public 18.34%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 22 Dec 2022, 1 resolution

The company's voting result (opens in a new tab)

  1. To approve the appointment of Mr. Prasad Raghava Menon (DIN: 00005078), as an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.67%

    Turnout: all 44.60% · promoters 69.68% · institutions 79.35% · other public 0.51%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 2 Aug 2022, 4 resolutions

Present: 5 promoters and 69 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt (a) the Audited Financial Statements of the Company for the financial year ended March 31, 2022, together with the reports of the Board of Directors and the Auditors’ thereon and (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2022, together with the report of the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.76%

    Turnout: all 47.61% · promoters 96.70% · institutions 51.86% · other public 0.27%

  2. To declare final dividend of Rs. 5/- (50) per equity share on a face value of Rs. 10 each, for the financial year 2021-22 as recommended by the Board.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.84%

    Turnout: all 47.64% · promoters 96.70% · institutions 51.97% · other public 0.27%

  3. To appoint a Director in place of Mr. Davuluri Saharsh Rao (DIN 02753145) who retires by rotation and, being eligible, offers himself for re-appointment.
    OrdinaryPromoters have an interest in it
    99.90% for0.10% against

    Against: promoters 0.00% · institutions 0.36% · other public 2.10%

    Turnout: all 47.64% · promoters 96.70% · institutions 51.97% · other public 0.27%

  4. Ratification of remuneration of Cost Auditors
    Ordinary
    91.94% for8.06% against

    Against: promoters 0.00% · institutions 30.67% · other public 2.24%

    Turnout: all 47.64% · promoters 96.70% · institutions 51.97% · other public 0.27%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 4 Aug 2026, 15 fund houses so far (houses' deadline to file 15 Oct 2026)

  • To receive, consider and adopt: (a) the Audited Financial Statements of the Company for the financial year ended March 31, 2026, together with the reports of the Board of Directors and the Auditors’ thereon; and (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the report of the Auditors thereonMoreLess
    15 for0 against
  • To declare final dividend of Rs. 34.00/- (340 %) per equity share of a face value of Rs. 10 each, for the financial year 2025-26 as recommended by the Board
    15 for0 against
  • To appoint a Director in place of Dr. Davuluri Rama Mohan Rao (DIN: 00107737), who retires by rotation and being eligible, offers himself for re-appointment
    15 for0 against
  • Payment of Commission to the Non-executive Directors of the Company
    15 for0 against
  • Appointment of Dr. Mauricio Futran (DIN: 11699767) as Non-Executive Non-Independent Director of the Company
    15 for0 against
  • Payment of professional fees to Dr. Mauricio Futran (DIN: 11699767) Non-Executive Non-Independent Director of the Company
    15 for0 against
  • Ratification of remuneration of Cost Auditors
    15 for0 against

Mutual fund votes, meeting of 5 Nov 2025, 27 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Re-designation of Mr. Davuluri Sucheth Rao (DIN: 00108880) as Executive Vice Chairman
    26 for0 against
  • Re-designation of Mr. Davuluri Saharsh Rao (DIN: 02753145) as Chief Executive Officer and Managing Director
    26 for0 against
2 proposals not matched to one resolution
  • Approve Re-Designation of Davuluri Saharsh Rao from Whole Time Director designated as Vice Chairman & Managing Director, as Chief Executive Officer & Managing Director
    1 for0 against
  • Approve Re-Designation of Davuluri Sucheth Rao, Whole-time Director designated as Vice Chairman & Chief Executive Officer, as Executive Vice Chairman
    1 for0 against
5 earlier meetings

Mutual fund votes, meeting of 26 Sep 2025, 27 fund houses

  • To approve the appointment of Dr. Ravi Shankar Gopinath (DIN: 00803847), as an Independent Director of the Company
    27 for0 against

Mutual fund votes, meeting of 30 Jul 2025, 26 fund houses

  • To receive, consider and adopt: (a) the Audited Financial Statements of the Company for the financial year ended March 31, 2025, together with the reports of the Board of Directors and the Auditors’ thereon; and (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, together with the report of the Auditors thereonMoreLess
    26 for0 against
  • To declare final dividend of Rs. 12.00/- (120 %) per equity share of a face value of Rs. 10 each, for the financial year 2024-25 as recommended by the Board.
    26 for0 against
  • To appoint a Director in place of Dr. Christopher M. Cimarusti (DIN: 02872948) who retires by rotation and, being eligible, offers himself for re-appointment.
    26 for0 against
  • To appoint a Director in place of Mr. Davuluri Saharsh Rao (DIN: 02753145) who retires by rotation and, being eligible, offers himself for re-appointment.
    26 for0 against
  • Appointment of Secretarial Auditor of the Company
    26 for0 against
  • Re-appointment of Mr. Davuluri Saharsh Rao (DIN: 02753145), as Whole Time Director, designated as Vice Chairman & Managing Director
    Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund, UTI Mutual Fund
    • Angel One Mutual FundGovernance concern: No absolute cap on variable pay; Remuneration practice is not linked with the individual performance of the director.
    • Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundCompliant with law. Governance concern: No absolute cap on variable pay; Remuneration practice is not linked with the individual performance of the director
    • HDFC Mutual FundMr. Davuluri Saharsh Rao, 46, is part of the promoter family and serves as the Managing Director and Vice Chairperson of Neuland Laboratories Limited. The proposed remuneration is high considering the size and complexity of the business. We do not support the resolution.
    • UTI Mutual FundDavuluri Saharsh Rao, 46, is part of the promoter family and serves as the Managing Director and Vice Chairperson of Neuland Laboratories Limited. His FY25 pay aggregated Rs. 100.5 mn. Based on the proposed terms, we estimate his FY26 pay at ~Rs. 123.1 mn, including commission. Through an addendum, the company has capped his commission at the lower of 2% of net profits or Rs. 100.0 mn. Based on this, we estimate his maximum pay over the tenure at Rs. 167.2 mn. Although we support his reappointment, we are unable to support the resolution due to the high levels of promoter executive compensation. While Davuluri Saharsh Rao’s pay is capped in absolute terms, the overall promoter pay remains high and is not commensurate with the company’s current scale of operations or when compared to peers. We do not support the resolution.
    18 for8 against
  • Ratification of remuneration of Cost Auditors
    26 for0 against

Mutual fund votes, meeting of 31 Jul 2024, 6 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt: (a) the Audited Financial Statements of the Company for the financial year ended March 31, 2024, together with the reports of the Board of Directors and the Auditors’ thereon; and (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, together with the report of the Auditors thereonMoreLess
    6 for0 against
  • To declare final dividend of Rs. 14.00/- [140 %] per equity share of a face value of Rs.10 each, for the financial year 2023-24 as recommended by the Board
    6 for0 against
  • To appoint a Director in place of Dr. Davuluri Rama Mohan Rao (DIN: 00107737) who retires by rotation and, being eligible, offers himself for re-appointment
    Against Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance concern: Combined position of Executive Director and Chairman
    3 for3 against
  • To appoint a Director in place of Mr. Davuluri Sucheth Rao (DIN: 00108880) who retires by rotation and, being eligible, offers himself for re-appointment
    6 for0 against
  • To reappoint statutory auditors of the Company and fix their remuneration
    5 for0 against
  • Ratification of remuneration of Cost Auditors
    6 for0 against
1 proposal not matched to one resolution
  • To re-appoint M/s. MSKA and Associates, Chartered Accountants (Registration No. Firm Registration No. 105047W) as a Statutory Auditors of the Company for a further consecutive term of five years, from the conclusion of this Annual General Meeting till the conclusion of Forty Fifth Annual General Meeting at such remuneration and out of pocket expenses, as may be decided by the Audit Committee and/ or Board of Directors of the Company.MoreLess
    1 for0 against

Mutual fund votes, meeting of 27 Jul 2023, 2 fund houses

  • To receive, consider and adopt: (a) the Audited Financial Statements of the Company for the financial year ended March 31, 2023, together with the reports of the Board of Directors and the Auditors’ thereon; and (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2023, together with the report of the Auditors thereonMoreLess
    2 for0 against
  • To declare final dividend of Rs. 10.00/- [100 %] per equity share of a face value of Rs.10 each, for the financial year 2022-23 as recommended by the Board
    2 for0 against
  • To appoint a Director in place of Dr.Christopher Cimarusti (DIN: 02872948) who retires by rotation and, being eligible, offers himself for re-appointment
    2 for0 against
  • To adopt a new set of Articles of Association of the Company as per the Companies Act, 2013
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundProvision for appointment Executive Chairperson, Alternate Directors; Enabling provision for perpetual appointments.
    1 for1 against
  • Re-appointment of Mr. Davuluri Sucheth Rao (DIN: 00108880), as Whole Time Director, designated as Vice Chairman & Chief Executive Officer
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. Governance concern: No absolute cap on variable pay; Similar remuneration paid to Promoter EDs since last 3 years.
    1 for1 against
  • Appointment of Mr. Sugata Sircar (DIN: 01119161), as an Independent Director of the Company
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. Governance concern: Unable to carry out his prime duty as CFO at other company, hence excessive time commitment.
    1 for1 against
  • Appointment of Ms. Pallavi Bhakru (DIN: 01526618), as an Independent Director of the Company
    2 for0 against
  • Continuation of directorship of Mrs. Bharati Rao (DIN: 01892516), as Non-Executive Independent Director on attaining the age of 75 years
    2 for0 against
  • Re-appointment of Mr. Homi Rustam Khusrokhan (DIN: 00005085), as an Independent Director of the Company for a further period of five years
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. Governance Concern: Director on the Board of Competitor Company.
    1 for1 against
  • Re-appointment of Dr. Davuluri Rama Mohan Rao (DIN: 00107737), as Whole Time Director, designated as Executive Chairman
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. Governance concern: Combined position of Executive Director and Chairman; No absolute cap on variable pay or total remuneration.
    1 for1 against
  • Revision in remuneration payable to Mr. Davuluri Saharsh Rao (DIN: 02753145), Whole Time Director, designated as Vice Chairman & Managing Director
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. Governance concern: No absolute cap on variable pay; Similar remuneration paid to Promoter EDs since last 3 years.
    1 for1 against
  • Ratification of remuneration of Cost Auditors
    2 for0 against

Mutual fund votes, meeting of 23 Nov 2022, 1 fund house

  • To approve the appointment of Mr. Prasad Raghava Menon (DIN: 00005078), as an Independent Director of the Company.
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Tax disputes

Reported in the filing for the quarter to Jun 2026.

  • Tax disputeThe Principal Commissioner of Income Tax, Hyderabad (Income Tax DepartmentSince 10 Apr 2015
    The hearing was initially scheduled for 9th July 2025 which was subsequently postponed to a later date.
    At the filing before: Disputed Income Tax Liability for Assessment Year 2004-05 : The Income tax authorities had re-opened the income tax assessment of the Company for the assessment year 2004- 05 later than the periods permitted by the provisions of the Income Tax Act, 1961 and thereby demanded an additional tax amount of Rs. 693.33 lacs on account of disallowance of certain prior period expenditure recognized by the Company in the computation of gross total income for the assessment year then ended. Aggrieved by the order of the Income Tax department, the management had filed an appeal with the higher authorities which had been successfully decided in favour of the Company. The Income Tax department has however filed an appeal with the Hon’ble High Court of Telangana in this regard, which is pending final outcome.MoreLess

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.